Dawit Getachew Assefa has a Master of Science Degree from Addis Ababa University in Ethiopia, and serves as a Clinical Trials Specialist. Since 2017, he has been imparting knowledge at Dilla University, Ethiopia. Additionally, he has practical experience as a Professional Nurse at Dilla University Referral Hospital and Sekota District Health Center.

In his professional tenure, he has served as a principal investigator in a measles vaccine adverse event surveillance trial in Ethiopia and as a Research Nurse at KNCV Tuberculosis Foundation, contributing to multi-country clinical research on TB Prevention therapy for people living with HIV.

Throughout his career, Dawit has amassed expertise in clinical research and evidence synthesis, including systematic reviews, meta-analyses, and network meta-analyses. His primary research interests revolve around poverty-related infectious diseases and neglected tropical infectious diseases, with a particular focus on malaria and tuberculosis. 

Dawit joined IDDO/WWARN as a WHO/TDR Fellow in 2024, and worked until February 2025 on the comparative effectiveness of Artemisinin Combination Therapy on haemoglobin recovery and gametocyte clearance in P. falciparum.